Cargando…
Phenotypic Assessment of Pathogenic Variants in GNAO1 and Response to Caffeine in C. elegans Models of the Disease
De novo mutations affecting the G protein α o subunit (Gαo)-encoding gene (GNAO1) cause childhood-onset developmental delay, hyperkinetic movement disorders, and epilepsy. Recently, we established Caenorhabditis elegans as an informative experimental model for deciphering pathogenic mechanisms assoc...
Autores principales: | Di Rocco, Martina, Galosi, Serena, Follo, Francesca C., Lanza, Enrico, Folli, Viola, Martire, Alberto, Leuzzi, Vincenzo, Martinelli, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957173/ https://www.ncbi.nlm.nih.gov/pubmed/36833246 http://dx.doi.org/10.3390/genes14020319 |
Ejemplares similares
-
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia
por: Di Rocco, Martina, et al.
Publicado: (2021) -
The recurrent pathogenic Pro890Leu substitution in CLTC causes a generalized defect in synaptic transmission in Caenorhabditis elegans
por: Pannone, Luca, et al.
Publicado: (2023) -
GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome
por: Danti, Federica Rachele, et al.
Publicado: (2017) -
Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling
por: Galosi, Serena, et al.
Publicado: (2022) -
C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples
por: Lanza, Enrico, et al.
Publicado: (2021)